This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Is Psychopharmacologic “Inoculation” Effective in Preventing Posttraumatic Stress Disorder?

Stephen M. Stahl, MD, PhD

Published: January 15, 2005

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Who gets PTSD and who doesn’ t? Perhaps half of all adult Americans will experience a traumatic event at some time in their lives, but studies estimate that only 25% of such individuals will develop PTSD, resulting in a lifetime prevalence rate of about 8%.1 Now it may be possible not only to identify those at high risk for developing PTSD but also to treat them before they get PTSD, and thus, in concept, to prevent them from getting PTSD.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 66

Quick Links: